So treatment should be given when needed..no need
Post# of 157968
Quote:
So treatment should be given when needed..no need to withhold for a year..
Agreed, but that's up to the FDA and given when the company must have first known about the leronlimab/PD-L1 inhibitor connection I believe the company already tried to amend. The fallback position is the DSMB.

